BioSentinel, Inc. is a leading biotechnology company specializing in the development of innovative tools and reagents for the study of botulinum neurotoxin (BoNT). With a strong focus on speed, sensitivity, and accuracy, their tests and assays set new standards in BoNT detection, while also reducing testing costs and eliminating the need for animal usage. With a state-of-the-art laboratory in Madison, WI, and collaborations with renowned institutions and organizations, BioSentinel is uniquely positioned to design BoNT detection technologies for both biodefense programs and pharmaceutical applications. Their suite of assays offers diverse detection and quantification capabilities, catering to various sample types and research needs.Generated from the website